Cardiac Troponin and Outcome in Decompensated Heart Failure With Preserved Ejection Fraction

Cardiovascular Diagnosis and Therapy - China
doi 10.21037/cdt.2017.03.17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

Biomarkers in Acutely Decompensated Heart Failure With Preserved or Reduced Ejection Fraction

American Heart Journal
Cardiovascular MedicineCardiology
2012English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Myocardial Injury and Cardiac Reserve Limitation in Heart Failure With Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Soluble Neprilysin Does Not Correlate With Outcome in Heart Failure With Preserved Ejection Fraction?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2016English

Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Echocardiographic Patterns of Cardiac Amyloidosis in Patients With Heart Failure With Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Non-Cardiac Comorbidities in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction

International Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy